These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15048146

  • 1. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
    Verma A, Williams S, Trifilio S, Zembower T, Mehta J.
    Bone Marrow Transplant; 2004 May; 33(10):1065-6. PubMed ID: 15048146
    [No Abstract] [Full Text] [Related]

  • 2. An update on the use of antifungal agents.
    Martinez R.
    J Bras Pneumol; 2006 May; 32(5):449-60. PubMed ID: 17268750
    [Abstract] [Full Text] [Related]

  • 3. Combination antifungal therapy for invasive aspergillosis.
    Cesaro S, Visintin G.
    Clin Infect Dis; 2005 Apr 01; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
    [No Abstract] [Full Text] [Related]

  • 4. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP.
    Am J Health Syst Pharm; 2003 Nov 15; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract] [Full Text] [Related]

  • 5. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
    Forestier E, Remy V, Lesens O, Martinot M, Hansman Y, Eisenmann B, Christmann D.
    Eur J Clin Microbiol Infect Dis; 2005 May 15; 24(5):347-9. PubMed ID: 15889298
    [Abstract] [Full Text] [Related]

  • 6. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P.
    J Clin Microbiol; 2005 Sep 15; 43(9):4902-4. PubMed ID: 16145172
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, Del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S.
    Transplantation; 2006 Feb 15; 81(3):320-6. PubMed ID: 16477215
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW, Kuijper EJ, Verweij PE, Kullberg BJ.
    Ned Tijdschr Geneeskd; 2004 Aug 21; 148(34):1679-84. PubMed ID: 15453120
    [Abstract] [Full Text] [Related]

  • 13. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Danaher PJ.
    N Engl J Med; 2005 Jan 27; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
    [No Abstract] [Full Text] [Related]

  • 14. Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
    Steinbach WJ.
    Curr Drug Targets Infect Disord; 2005 Sep 27; 5(3):203-10. PubMed ID: 16181140
    [Abstract] [Full Text] [Related]

  • 15. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Clemons KV, Espiritu M, Parmar R, Stevens DA.
    Antimicrob Agents Chemother; 2005 Dec 27; 49(12):4867-75. PubMed ID: 16304147
    [Abstract] [Full Text] [Related]

  • 16. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL.
    J Antimicrob Chemother; 2007 Aug 27; 60(2):385-93. PubMed ID: 17561501
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    Gahn B, Schub N, Repp R, Gramatzki M.
    Eur J Med Res; 2007 Aug 16; 12(8):337-40. PubMed ID: 17933709
    [Abstract] [Full Text] [Related]

  • 19. Successful antifungal combination therapy with voriconazole and caspofungin.
    Schuster F, Moelter C, Schmid I, Graubner UB, Kammer B, Belohradsky BH, Führer M.
    Pediatr Blood Cancer; 2005 Jun 15; 44(7):682-5. PubMed ID: 15700260
    [Abstract] [Full Text] [Related]

  • 20. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
    Manfredi R, Sabbatani S.
    Scand J Infect Dis; 2006 Jun 15; 38(10):950-1. PubMed ID: 17008248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.